Resveratrol improves hepatic ischemia-reperfusion injury by inhibiting neutrophils via the ERK signaling pathway - 26/02/23
, Dong Zhang a, b, c, d, ⁎
, Guangyong Sun a, b, c, d, ⁎ 
Abstract |
Hepatic ischemia-reperfusion injury (HIRI) is the main complication and even mortality in the setting of hepatic surgery or transplantation. Inflammation, especially the neutrophil response, plays important roles during the process of HIRI. In this study, we found that resveratrol preintervention ameliorated IRI-induced hepatic injury and neutrophil inflammatory responses in the liver. Moreover, RNA-sequencing analysis showed that resveratrol inhibited the functions of neutrophils, such as survival, cell cycle, migration and chemotaxis, oxidative stress and secretion of proinflammatory cytokines. Resveratrol restrained oxidative stress and the inflammatory response of neutrophils via inhibition of endothelin 1 autocrine signaling by suppressing the ERK signaling pathway. These data provide more evidence for the immunomodulatory role of resveratrol and enrich our understanding of immune strategies to improve HIRI.
Il testo completo di questo articolo è disponibile in PDF.Graphical Abstract |
Resveratrol preintervention ameliorated IRI-induced hepatic injury and neutrophil inflammatory responses. Mechanistically, resveratrol restrained neutrophils proinflammation via inhibition of endothelin 1 autocrine signaling by suppressing the ERK signaling pathway.
Highlights |
• | Resveratrol intervention ameliorates hepatic ischemia-reperfusion injury (HIRI). |
• | Resveratrol inhibits neutrophils survival and inflammation responses in HIRI. |
• | Resveratrol suppresses neutrophils via inhibition on their endothelin 1 autocrine. |
• | Resveratrol inhibits neutrophil endothelin 1 secretion through ERK/c-Fos pathway. |
Abbreviations : HIRI, IRI, ALT, AST, RES, ROS, NET, CitH3, MDA, GSH, GSH-PX
Keywords : Hepatic ischemia-reperfusion injury, Resveratrol, Neutrophils, Endothelin 1, ERK signaling pathway
Mappa
Vol 160
Articolo 114358- aprile 2023 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
